Menu Back toSession-05-What-We-Should-Consider-Accelerating-eSource-Adoption-in-Clinical-Research

The 23rd DIA Japan Annual Workshop for Clinical Data Management


Session-05: What We Should Consider Accelerating eSource Adoption in Clinical Research?

Session Chair(s)

Naoko  Yamamoto, MS

Naoko Yamamoto, MS

  • Osaka University Hospital, Japan
Misato  Kuwagaki, MS

Misato Kuwagaki, MS

  • Consultant, Clinical Laboratory and Data Sciences-eSource/Clinilcal Risk
  • Eli Lilly Japan K.K., Japan

Speaker(s)

Junhei  Matsuzawa, MBA, MSc

Challenges to More Efficient Pivotal Study by eSource Method.

Junhei Matsuzawa, MBA, MSc

  • Project Manager, Development Department 2
  • The Research Foundation for Microbial Diseases of Osaka University, Japan
Makoto  Takeda

Challenges to More Efficient Pivotal Study by eSource Method in Terms of CRO

Makoto Takeda

  • Director Data Management I
  • A2 Healthcare Corporation, Japan
Sachiko  Abe

Challenges to More Efficient Pivotal Study by eSource Method in Terms of SMO

Sachiko Abe

  • NEUES Corporation, Japan
Amy  Cramer, BSN, MS, RN

Comparison of Approach for Using EHR Data in Clinical Studies(Tentative)

Amy Cramer, BSN, MS, RN

  • Global Product Development Strategic Partnerships
  • Pfizer Inc, United States
Hideo  Chubachi

Points to Consider on Reliability of eSource Data

Hideo Chubachi

  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan